Clinical Chemistry, Malmö
41 – 50 of 1351
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Comprehensive biobanking strategy with clinical impact at the European Cancer Moonshot Lund Center
- Contribution to journal › Scientific review
-
Mark
Genome-wide association study of prostate-specific antigen levels in 392,522 men identifies new loci and improves prediction across ancestry groups
- Contribution to journal › Article
-
Mark
Mitochondrial proteome landscape unveils key insights into melanoma severity and treatment strategies
- Contribution to journal › Article
-
Mark
Cold activation in PT-INR samples–Myth or reality in the modern laboratory?
- Contribution to journal › Article
-
Mark
Practical handling of hemolytic, icteric and lipemic samples for coagulation testing in European laboratories. A collaborative survey from the European Organisation for External Quality Assurance Providers in Laboratory Medicine (EQALM)
- Contribution to journal › Article
-
Mark
Unbiased Drug Target Prediction Reveals Sensitivity to Ferroptosis Inducers, HDAC and RTK Inhibitors in Melanoma Subtypes
- Contribution to journal › Article
-
Mark
A perspective on integrating digital pathology, proteomics, clinical data and AI analytics in cancer research
- Contribution to journal › Scientific review
-
Mark
MicroRNA-379 Modulates Prostate-Specific Antigen Expression Through Targeting the Androgen Receptor in Prostate Cancer
- Contribution to journal › Article
- 2024
-
Mark
Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death-Results from the Norwegian Prostate Cancer Consortium
- Contribution to journal › Article
-
Mark
Expression patterns of novel immunotherapy targets in intermediate- and high-grade lung neuroendocrine neoplasms
- Contribution to journal › Article
